# Defying the Odds: A Case Report of ACTG2-Related Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome With Complete Recovery

**Authors:** Naila Almoosa, Nagham Alshehabi, Farheen Khan, Mira Elmiaari, Alia Magzoub, Maysa Saleh

PMC · DOI: 10.7759/cureus.84449 · Cureus · 2025-05-20

## TL;DR

A rare congenital disorder called MMIHS typically has poor outcomes, but a three-month-old infant showed complete recovery without major interventions.

## Contribution

This case report highlights an atypical favorable outcome in ACTG2-related MMIHS through early diagnosis and infection management.

## Key findings

- The patient avoided lifelong parenteral nutrition and surgical interventions.
- Symptomatic management after resolving an infection led to full recovery.
- Early diagnosis and targeted treatment improved outcomes in a severe congenital disorder.

## Abstract

Visceral myopathy is a rare and complex congenital disorder primarily impacting the gastrointestinal and urologic systems. Among its manifestations, megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) represents the most severe form. Typically, this condition has a poor prognosis, with all reported cases necessitating lifelong parenteral nutrition, frequent surgical interventions, and intermittent catheterization. We present the case of a three-month-old female infant with a history of ACTG2-related MMIHS who presented with oliguria, emesis (non-bilious to bilious), and fever of 38.9°C over a two-day period. A gastrointestinal panel identified enteroaggregative Escherichia coli, and imaging revealed distended bowel loops without evidence of ischemia, microcolon, or obstructive lesions. The distended bladder required temporary catheterization, which was later removed. Initial parenteral nutrition was discontinued after eight days as the infant tolerated oral feeds well. The hospitalization was further complicated by a urinary tract infection and thrombocytosis, but the patient was ultimately discharged on full oral feeds with spontaneous urine output. This case contrasts the typical poor prognosis of visceral myopathy and MMIHS with a favorable outcome. The patient, who led an asymptomatic life until three months of age, avoided surgical interventions, long-term parenteral nutrition, and intermittent catheterization, interventions commonly required for MMIHS. After identifying an underlying infection that triggered pseudo-obstructive symptoms, symptomatic management was implemented. Once the infection resolved, no further interventions were necessary. This approach was not only cost-effective but also reduced the physical and emotional burden of the family, underscoring the importance of early diagnosis and targeted treatment for positive outcomes.

## Linked entities

- **Genes:** ACTG2 (actin gamma 2, smooth muscle) [NCBI Gene 72]
- **Diseases:** megacystis-microcolon-intestinal hypoperistalsis syndrome (MONDO:0025986), visceral myopathy (MONDO:0020754)

## Full-text entities

- **Genes:** ACTG2 (actin gamma 2, smooth muscle) [NCBI Gene 72] {aka ACT, ACTA3, ACTE, ACTL3, ACTSG, MMIHS5}
- **Diseases:** congenital disorder (MESH:D009358), oliguria (MESH:D009846), ischemia (MESH:D007511), urinary tract infection (MESH:D014552), emesis (MESH:D014839), Visceral myopathy (MESH:D007418), thrombocytosis (MESH:D013922), MMIHS (MESH:C536138), infection (MESH:D007239), fever (MESH:D005334)
- **Species:** Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12177678/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12177678/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12177678/full.md

---
Source: https://tomesphere.com/paper/PMC12177678